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Department of Biochemistry and Cell Biology, Stony Brook University, Stony Brook, New YorkABSTRACT Because transmembrane (TM) protein localization, or nonlocalization, in ordered membrane domains (rafts) is a
key to understanding membrane domain function, it is important to define the origin of protein-raft interaction. One hypothesis is
that a tight noncovalent attachment of TM proteins to lipids that have a strong affinity for ordered domains can be sufficient to
induce raft-protein interaction. The sterol-binding protein perfringolysin O (PFO) was used to test this hypothesis. PFO binds
both to sterols that tend to localize in ordered domains (e.g., cholesterol), and to those that do not (e.g., coprostanol), but it
does not bind to epicholesterol, a raft-promoting 3a-OH sterol. Using a fluorescence resonance energy transfer assay in model
membrane vesicles containing coexisting ordered and disordered lipid domains, both TM and non-TM forms of PFO were found
to concentrate in ordered domains in vesicles containing high and low-Tm lipids plus cholesterol or 1:1 (mol/mol) cholesterol/
epicholesterol, whereas they concentrate in disordered domains in vesicles containing high-Tm and low-Tm lipids plus 1:1
(mol/mol) coprostanol/epicholesterol. Combined with previous studies this behavior indicates that TM protein association with
ordered domains is dependent upon both the association of the protein-bound sterol with ordered domains and hydrophobic
match between TM segments and rafts.INTRODUCTIONLipid rafts are tightly packed sphingolipid and cholesterol-
rich liquid-ordered (Lo)membrane domains that are believed
to coexist in cells with loosely packed disordered domains
composed mostly of unsaturated lipids (1,2). Rafts have
been proposed to serve as platforms that regulate protein-
protein interaction and are believed to serve many functions
in signal transduction, protein trafficking, and pathogenesis
(1,2). Proteins that reside on the plasma membrane have
different affinities for raft domains (3–5). Several mecha-
nisms have been proposed as possible driving forces for
transmembrane (TM) protein association with lipid rafts.
One idea is that TM proteins might be dragged into rafts
by interacting with raft components, such as saturated fatty
acids, lipids with saturated acyl chains (e.g., sphingolipids),
or raft-associating sterols (e.g., cholesterol). However, how
these interactions impart raft affinity to TM proteins, and/
or whether these interactions are sufficient to drive TM
protein insertion into lipid rafts has not been confirmed.
Perfringolysin O (PFO) is an ideal protein to study the
interaction between membrane proteins and lipid rafts.
PFO belongs to the family of cholesterol-dependent cytoly-
sins (CDCs), and forms large homooligomeric pore
complexes comprising up to 50 subunits in cholesterol-con-
taining membranes (6). The ability of CDCs to specifically
recognize cholesterol-rich regions of cell membranes has
led to the hypothesis that CDCs are targeted to and bind
lipid rafts (7). For example, PFO, listeriolysin O, and aero-
lysin have been reported to associate with raft domains,Submitted July 11, 2013, and accepted for publication November 1, 2013.
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brane-bound toxin monomers (8–10). Both intact PFO and
derivatives of PFO membrane binding domain (domain 4)
have been used as markers of cholesterol-rich regions of
cell membranes (10–12). Although PFO is not a typical
TM protein, as it has a TM b-barrel, like TM residues in
TM a-helical proteins, TM residues in PFO should also be
unable to pack tightly with the linear acyl chains of lipids.
Therefore, the principles determining PFO interaction with
lipid rafts should be similar to those for a-helical membrane
proteins.
Previous reports indicated that membrane cholesterol
serves as the cellular receptor for PFO and some other
CDCs, and is necessary to induce the conformational
changes for PFO membrane insertion and pore formation
(13). However, although PFO was found to colocalize
with raft markers, such as flotillin and Src family kinases
(10–12), to date, there is no experimental evidence for the
necessity of lipid rafts for PFO activity in vitro (14–16).
Recent work in model membranes has shown that PFO
binds to and forms pores more readily in vesicles composed
of unsaturated lipids that do not form ordered domains,
while tightly packing phospholipids, which interact
strongly with sterols and form ordered domains, have been
shown to interfere with the interaction of PFO with mem-
branes, in the sense that in membranes composed of tightly
packed lipids, a higher concentration of sterol is needed for
PFO to interact with membranes (14–16). This led to the
hypothesis that PFO may insert into disordered domains
and then move into ordered domains subsequent to insertion
(16). Even so, it is not clear whether PFO raft affinity is
directly related to the raft affinity of cholesterol, or duehttp://dx.doi.org/10.1016/j.bpj.2013.11.002
2734 Lin and Londonto other the properties of the protein upon binding to choles-
terol/membranes.
Here, we used two sterols in addition to cholesterol to
separate the roles of cholesterol in PFO binding to mem-
branes and raft association. One is coprostanol, which con-
tains a 3b-hydroxyl group that can interact with PFO, but
which disrupts ordered domain formation (16,17). The other
is epicholesterol, which contains a 3a-hydroxyl group and
can promote ordered domain formation, but which does
not interact with PFO (16,17). Using various combinations
of these sterols the affinity of PFO for ordered domains on
lipid vesicles with coexisting ordered and disordered do-
mains was measured by fluorescence resonance energy
transfer (FRET). The results show that PFO has a high affin-
ity for ordered domains in vesicles containing cholesterol or
1:1 cholesterol/epicholesterol, but has a high affinity for
disordered domains in vesicles containing 1:1 coprostanol/
epicholesterol. This indicates that PFO association with
ordered domains is dependent upon the raft-associating
properties of PFO-bound sterols.MATERIALS AND METHODS
Materials
1,2-dimyristoleoyl-sn-glycero-3-phosphocholine (DMoPC), 1,2-diphyta-
noyl-sn-glycero-3-phosphocholine (DPhPC), 1,2-distearoyl-sn-glycero-3-
phosphocholine (DSPC), cholesterol (ovine wool), ganglioside M1 (GM1),
sphingomyelin (SM; egg), 1,2-dipalmitoyl-sn-glycero-3-phosphoethanol-
amine-N-pyrenesulfonyl (pyrene-DPPE), 1,2-diphytanoyl-sn-glycero-3-
phosphoethanolamine-N-(7-nitro-2-1,3-benzoxadiazol-4-yl) (NBD-DPhPE),
and 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(lissamine rhoda-
mine B sulfonyl) (Rho-DOPE) were purchased from Avanti Polar Lipids
(Alabaster, AL). Lipids were stored in ethanol or chloroform at 20C.
Concentrations were determined by dry weight or by absorbance, using
an ε of 35,000 cm1 M1 at 350 nm for pyrene-DPPE in methanol,
95,000 cm1 M1 at 560 nm for Rho-DOPE in methanol, and
21,000 cm1 M1 at 463 nm for NBD-DPhPE in methanol (18). The
sterols, 5-cholesten-3a-ol (epicholesterol) and 5b-cholestan-3b-ol (coprosta-
nol), were purchased from Steraloids (Newport, RI). The labeling re-
agents N-(4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-indacene-3-yl)
methyl)iodoacetamide (BODIPY-FL) and 6-acryloyl-2-dimethylaminonaph-
thalene (acrylodan) were purchased from Invitrogen (Grand Island, NY).
Acetyl-K2W2L8AL8W2K2-amide (LWpeptide)was purchased fromAnaspec
(San Jose, CA) and used without further purification. Cholera toxin B (CT-B)
subunit was purchased from EMD Chemicals (Gibbstown, NJ). All other
chemicals were reagent grade.Purification and fluorescent labeling of PFO
A functional cysteine-less derivative of wild-type PFO (PFO C459A) and a
prepore mutant (PFO C459A Y181A), which cannot insert to form TM
segments, were gifts of A. Heuck, U. Mass. Amherst. PFO variants of these
proteins with an Ala to Cys substitution at residue 215 were generated by
the QuickChange site-directed mutagenesis kit (Stratagene, Santa Clara,
CA) as previously described (19). We refer to PFO C459A A215C as
WT in this report because it has wild-type length TM segments, and inserts
into membrane identically to PFO C459A, which is a fully active form
of PFO. We refer to PFO C459A Y181A A215C as prepore or prepore
mutant PFO. PFO was expressed in Escherichia coli BL21(DE3)pLysSBiophysical Journal 105(12) 2733–2742and purified similarly as described previously (16). The purified PFO was
stored in phosphate-buffered saline (PBS, 1.8 mM KH2PO4, 10 mM
Na2HPO4, 137 mM NaCl, and 2.7 mM KCl at pH 7.4) at a concentration
of ~20–30 mM at 20C. Labeling of PFO at Cys-215 with BODIPY-FL
or acrylodan was carried out similarly as described previously (19). The
fluorescent-labeled PFO was stored in PBS pH 7.4 at a concentration
of ~4–5 mM at 20C.Preparation of lipid vesicles
Multilamellar vesicles (MLVs) were prepared with the desired mixtures of
lipids. Lipids in solvent were mixed and then dried with N2. They were then
redissolved in CHCl3 and redried under N2 and then high vacuum for at
least 1 h. The redried lipid mixtures were then dispersed in PBS, pH 5.1,
at 70C to give the desired final concentration and agitated at 55C for
15 min using a VWR multitube vortexer (Westchester, PA) placed within
a convection oven (GCA Corp., Precision Scientific, Chicago, IL). Samples
were cooled to room temperature (~23C) before use.Fluorescence intensity measurements
Fluorescence emission intensity was measured (unless otherwise noted) at
room temperature (~23C) on a SPEX Fluorolog 3 spectrofluorimeter
(Jobin-Yvon, Edison, NJ). For fixed wavelength measurements, excitation
and emission wavelength sets used (in nm) were (280, 340) for tryptophan,
(350,448) for acrylodan, (490,510) for BODIPY, and (350, 379) for pyrene-
DPPE. Unless otherwise noted, fluorescence intensity in single background
samples lacking fluorophore was subtracted. For acrylodan-labeled PFO
emission spectra, samples and backgrounds were excited at 350 nm, and
emission was acquired from 420 to 560 nm.Measurement of vesicle binding by tryptophan
fluorescence
The ability of WT PFO to associate with lipid vesicles was assessed by
measuring the increase in intrinsic Trp emission intensity, which occurs
when Trp residues located at the tip of domain 4 come into contact with
membrane (20). A small aliquot of PFO was added to 1 ml of an MLV sus-
pension containing 500 mM total lipids in PBS pH 5.1. The final PFO con-
centration was 55 nM. After 1 h incubation at room temperature, Trp
emission intensity was measured as described previously. (Note that PFO
interaction with membranes is enhanced at low pH. This may reflect a phys-
iological role for PFO pore formation in acidic organelles (16,21,22).)Measurement of vesicle insertion by acrylodan
fluorescence
PFO-membrane interaction was also monitored by the changes in the acryl-
odan fluorescence intensity of WT PFO labeled with acrylodan on Cys-215.
Residue 215 becomes buried in the bilayer when PFO inserts into the
bilayer and forms TM b-hairpins (23). To do this, a small aliquot of
acrylodan-labeled PFOwas added to 1 ml of an MLV suspension containing
500 mM total lipids in PBS pH 5.1. The final acrylodan-labeled PFO con-
centration was 25 nM. After 1 h incubation at room temperature, acrylodan
emission spectra were measured as described above.Measurement of vesicle association by
centrifugation
The ability of WT and prepore PFO to associate with vesicles was assessed
by ultracentrifugation. MLVs (500 mM total lipid) composed of different
lipid species with 40 or 45 mol % sterol were prepared in 1 ml of PBS
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at room temperature. The final BODIPY-labeled PFO concentration was
25 nM. Samples were then spun for 30 min in a Beckman L8-85 ultracen-
trifuge (Indianapolis, IN) at 84,000 g at 4C. This was sufficient to pellet
all of the vesicles. After spinning, supernatants containing the unbound
PFO were removed, and pellets containing the MLVs and bound PFO
were resuspended in 1 ml of PBS, pH 5.1. BODIPY fluorescence was
then measured for both the supernatant and the pellet.Detection of domain formation by FRET
FRET measurements were made in 1 ml MLV samples dispersed in PBS
pH 5.1 prepared as described previously (19,24). Samples contained
500 mM total lipids with 0.05 mol % pyrene-DPPE as a donor and 2 mol %
Rho-DOPE as an acceptor in F samples. Fo samples contained only donor.
The fluorescence of pyrene-DPPE was measured from 15 to 60C as
described previously (24). Fluorescence measurements were taken every
5C. The ratio of donor fluorescence intensity in the presence of acceptor
to its absence (F/Fo)was calculated.Backgroundfluorescencewas negligible.A
BFRET assay of raft affinity
FRETexperimentswere carried out to assessWTandpreporePFOaffinity for
raft domains similarly to as described byNelson et al. (18) and Lin et al. (19),
with 2 mol % NBD-DPhPE used as the FRET acceptor. Briefly, 100 ml of
MLVs prepared in PBS, pH 5.1 at a total lipid concentration of 5 mM were
incubatedwith 3mg PFO. Two types of sampleswere prepared. F sample ves-
icles contained FRETacceptor (2mol%NBD-DPhPE of total lipid). Fo sam-
ple vesicles lacked FRET acceptor. To measure CT-B raft affinity, the same
procedure was followed as for PFO, but vesicles contained an additional
2 mol % ganglioside GM1, and 5 mg CT-B chain. For samples with LW pep-
tide, peptidewas added froman ethanolic stock solution to lipids before prep-
aration of the MLVs at a concentration of 0.25 mol % of total lipids. After
incubation at room temperature for at least 1 h, samples were diluted with
PBS pH 5.1 to 1 ml and Trp emission intensity was measured as described
above. The ratio of the local concentration of acceptor around the donor in
a membrane containing both liquid ordered and liquid disordered domains
(CLoLd) relative to that in a homogeneous membrane lacking domains
(CLd) is given by the equation: CLoLd/CLd ¼ ln (F/Fo)LoLd/ln (F/Fo)Ld (18).
Uncorrected F/Fo is the ratio of measured donor fluorescence (after subtrac-
tion of background fluorescence) in the presence of acceptor to that in its
absence (¼ Fmeasured/Fomeasured). Corrected F/Fo ¼ (Fmeasured – xFunbound)/
(Fomeasured – xFunbound), where Funbound is the Trp fluorescence of the same
amount of PFO in the samples would have if it was fully unbound to vesicles,
and x ¼ fraction of unbound protein derived from the centrifugation assay.Laser scanning microscopy
Giant unilamellar vesicles (GUVs) were prepared using the electroforma-
tion method as previously described (19,25). The inclusion in the GUVs
of the fluorescently labeled lipid Rho-DOPE (0.02 mol %), a marker for
disordered domains (26), allowed the optical visualization of domains.
After electroformation, GUVs were observed under confocal laser scanning
microscopy and 3D representations constructed (19). All of the measure-
ments were performed at room temperature.FIGURE 1 PFO interaction with vesicles composed of DSPC/DMoPC/
sterol. Trp fluorescence (A) of 55 nM PFO and acrylodan fluorescence
(B) of 25 nM acrylodan-labeled PFO interacting with MLVs (500 mM total
lipid) composed of 1:1 DSPC/DMoPC with different amounts of choles-
terol (C), coprostanol ( ), epicholesterol ( ), 1:1 cholesterol/epicholes-
terol (;), or 1:1 coprostanol/epicholesterol (>) were measured in PBS
pH 5.1. Average (mean) values and SD values from triplicates are shown.
Error bars are not shown where they are too small to illustrate.RESULTS
PFO interacting with membranes containing
different sterols
The interaction of WT PFO with model membrane vesicles
having compositions appropriate for domain associationstudies was monitored by the increase of domain 4 Trp
emission intensity observed when PFO associates with
membranes (20). These studies were necessary to define
what lipid mixtures would tightly bind to PFO, and thus
be suitable for FRET experiments defining PFO association
with ordered and disordered domains.
We started with DSPC/DMoPC mixtures with choles-
terol. We previously found a 1:1 (mol/mol) mixture of
DSPC/DMoPC could form coexisting ordered and disor-
dered domains with cholesterol (18,19). In agreement with
previous observations (16,20), a cholesterol-dependent in-
crease in Trp fluorescence was detected when PFO interacts
with vesicles composed of DSPC/DMoPC and sufficient
cholesterol (Fig. 1 A), with the binding threshold (whichBiophysical Journal 105(12) 2733–2742
FIGURE 2 Detection of domain formation in vesicles composed of
DSPC/DMoPC/sterol by FRET. MLVs (500 mM total lipid) composed of
2736 Lin and Londonwe are defining here as the sterol concentration giving a
half-maximal fluorescence increase) at ~35 mol % choles-
terol. A similar binding curve and threshold sterol concen-
tration for PFO binding was observed when PFO was
incubated with DSPC/DMoPC vesicles containing coprosta-
nol, indicating that coprostanol could mediate PFO-mem-
brane association, in agreement with previous results in
DOPC vesicles (16). In contrast, PFO did not interact with
DSPC/DMoPC vesicles containing epicholesterol. This
lack of interaction also agrees with previous studies in
DOPC vesicles with epicholesterol (16).
Binding of PFO to vesicles also was observed in vesicles
containing 1:1 (mol/mol) cholesterol/epicholesterol or cop-
rostanol/epicholesterol mixtures (Fig. 1 A). Interestingly,
the threshold concentration of cholesterol or coprostanol
needed to bind PFO decreased by up to twofold in the pres-
ence of epicholesterol (in 1:1 3b-sterol/epicholesterol mix-
tures a 40 mol % total sterol threshold for binding is
equivalent to 20 mol % of the PFO binding sterol). This
may be due to competition of epicholesterol with choles-
terol or coprostanol for interaction with phospholipids,
which can increase cholesterol or coprostanol exposure to
water and thus reactivity with PFO (14,27,28).
Next, the membrane insertion of PFO TM b-barrel was
detected by the fluorescence intensity of a fluorescent probe,
acrylodan attached to Cys-215, a residue located within the
TM hairpin that forms when PFO undergoes TM insertion
(23). There was a steep sterol-dependent increase of acrylo-
dan fluorescence observed when PFO interacts with model
membranes containing an increasing amount of sterols.
The increase in acrylodan fluorescence occurred at the
same sterol concentration as the increase of Trp fluores-
cence (Fig. 1 B), indicating that in these lipid mixtures,
once membrane-bound, PFO efficiently unravels its domain
3 a-helical bundles and inserts the residues from these seg-
ments into the lipid bilayer. Overall, these studies indicated
that DSPC/DMoPC vesicles with high amounts of sterol
(>40 mol %) would be suitable for FRET studies.
PFO interaction and insertion into membranes was also
studied on vesicles composed of 1:1 SM/DMoPC, DSPC/
DPhPC, and SM/DPhPC, all with various sterols at various
concentrations. Similar Trp and acrylodan fluorescence
changes were seen in all the lipid mixtures examined
(Fig. S1 in the Supporting Material), indicating that these
mixtures would also be suitable for FRET studies when a
high sterol concentration was used.DMoPC with 45 mol % cholesterol ( ), DMoPC with 45 mol % 1:1 copro-
stanol/epicholesterol ( ), 1:1 DSPC/DMoPC with 45 mol % cholesterol
(-), 1:1 DSPC/DMoPC with 45 mol % 1:1 cholesterol/epicholesterol
( ), or 1:1 DSPC/DMoPC with 45 mol % 1:1 coprostanol/epicholesterol
(A) were prepared in PBS pH 5.1. F samples contained both FRET donor
(0.05 mol % pyrene-DPPE) and FRET acceptor (2 mol % Rho-DOPE). Fo
samples only contained FRET donor (0.05 mol % pyrene-DPPE). The ratio
of donor fluorescence in the presence of acceptor to that in its absence
(F/Fo) is graphed. Average (mean) values and SD values from triplicates
are shown. Abbreviations: chol ¼ cholesterol; epichol ¼ epicholesterol;
and cop ¼ coprostanol.Vesicles containing mixtures of coprostanol and
epicholesterol form ordered domains
To study PFO raft affinity, lipid compositions forming coex-
isting ordered and disordered domains are required. To
confirm that the compositions studied previously (all of
which contain a mixture of a high Tm-lipid, which tends to
form ordered domains, and a low Tm-lipid, which tends toBiophysical Journal 105(12) 2733–2742form disordered domains) would actually form coexisting
ordered and disordered domains in the presence of a high
concentration of sterol, a FRET method was used (24). In
this method, when a membrane has coexisting ordered and
disordered domains, the segregation of donor-labeled and
acceptor-labeled lipids with different affinities for ordered
and disordered domains results in a decrease in FRET,
which is detected as an increase in the normalized donor
fluorescence (F/Fo). To measure FRET, the acceptor used
was Rho-DOPE, which partitions strongly into Ld domains,
whereas the donor used, pyrene-DPPE, has a significant
affinity for Lo domains.
As shown in Fig. 2, at room temperature weaker pyrene to
rhodamine FRET (higher F/Fo) was observed in 1:1 DSPC/
DMoPC vesicles containing cholesterol, a 1:1 mixture
of cholesterol/epicholesterol, or a 1:1 mixture of coprosta-
nol/epicholesterol than that measured in homogeneous
(domain-lacking) DMoPC vesicles with the same sterols.
This is indicative of coexisting ordered and disordered
domain formation in the DSPC/DMoPC-containing sam-
ples. (We did not use pure coprostanol because it tends to
inhibit domain formation (see Discussion).) A sigmoidal
increase of FRET upon increasing temperature was ob-
served, such that at high temperature FRET was similar in
samples containing DSPC/DMoPC and those just contain-
ing DMoPC. This shows that the ordered domains melted
(i.e., transitioned from ordered to disordered) at high tem-
perature, consistent with previous results (24).
Somewhat stronger FRET (lower F/Fo) at low tempera-
tures was observed in DSPC/DMoPC vesicles with a 1:1
AB
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DSPC/DMoPC vesicles containing cholesterol or a 1:1
cholesterol/epicholesterol mixture, suggesting that smaller
or fewer domains might be formed in the vesicles containing
1:1 coprostanol/epicholesterol (24). This could be explained
by the fact that coprostanol disrupts domain formation (17).
Domain formation similar to that in vesicles with DSPC/
DMoPC was detected in liposomes composed of SM/
DMoPC, DSPC/DPhPC, and SM/DPhPC in the presence
of cholesterol or 1:1 mixtures of coprostanol/epicholesterol
(Fig. S2).
The FRET assay does not define what type of ordered
domains are present (gel or liquid ordered) in samples con-
taining lipid mixtures with epicholesterol or coprostanol/
epicholesterol. To define this, microscopy studies on GUVs
containing various sterols were carried out. Lo domains are
rounded, whereas gel domains have jagged, highly irregular
shapes (29–31). Fig. 3 A shows that mixtures of high-Tm and
low-Tm lipids with epicholesterol form Lo domains. We also
examined domains in GUVs containing epicholesterol/cop-
rostanol mixtures. For mixtures of high Tm and low Tm lipids
with 1:1 coprostanol/epicholesterol, domains were too small
to see (even though easily detected by FRET) at any concen-
trationwithmixtures of lipids containingDMoPCor contain-
ing SM, and could only be seen at very low epicholesterol
concentrations (maximum 12.5 mol % epicholesterol) for
mixtures of DSPC/DPhPC. However, Lo domains were
observed in DSPC/DPhPC at 20 mol % epicholesterol in
1:2 coprostanol/epicholesterol (Fig. 3 B).FIGURE 3 Fluorescence micrographs of GUVs show formation of coex-
isting Lo and Ld domains in the presence of epicholesterol and epicholes-
terol plus coprostanol. (A) GUVs composed of high-Tm lipid, low-Tm lipid,
and epicholesterol: (a) 1:1 DSPC/DMoPC with 22.5 mol % epicholesterol;
(b) 1:1 SM/DMoPC with 22.5 mol % epicholesterol; (c) 1:1 DSPC/DPhPC
with 20 mol % epicholesterol; and (d) 1:1 SM/DPhPC with 20 mol %
epicholesterol. The scale bar is 5 mm. Dashed white line is added to
help visualize vesicle perimeter. (B) Two representative micrographs of
GUVs composed of 1:1 DSPC/DPhPC with 10 mol % coprostanol and
20 mol % epicholesterol. The scale bar for the micrograph on the left is
10 mm and on the right is 5 mm. Abbreviation: epichol ¼ epicholesterol.
Vesicles in (A) and (B) were labeled with 0.02 mol % Ld-marker Rho-
DOPE. To see this figure in color, go online.FRET assay reveals sterol structure controls PFO
raft affinity
Using the lipid compositions studied above, a different FRET
assay we developed previously was used to study the effect
of sterols on PFO affinity for ordered domains (rafts)
(18,19). FRET from PFO Trp (donor) to the acceptor probe
lipid NBD-DPhPE, which has bulky acyl chains and parti-
tions favorably into Ld domains (19), was measured to
evaluate PFO association with rafts. The basis of the assay
is that in membranes with coexisting Lo and liquid-disor-
dered (Ld) domains, FRET is weak when PFO associates
with acceptor-depleted Lo domains and strong when it asso-
ciates with acceptor-rich Ld domains. To compare FRET
values for proteins with different inherent FRETefficiencies,
CLoLd/CLd, which describes the effective local acceptor con-
centration around protein molecules in domain-containing
membranes (CLoLd) relative to that in the homogeneous Ld
membranes (CLd), was used (18,19). The effective local
(i.e., within FRET range) acceptor concentration is high
when a protein partitions into a domain with a high concen-
tration of acceptor (i.e., Ld domains in these samples) and
low when a protein partitions into domains with a low con-
centration of acceptor (i.e., Lo domains in these samples).
High CLoLd/CLd values indicate that a protein has a highaffinity for Ld domains, whereas low CLoLd/CLd indicates a
protein has a high affinity for Lo domains.
To calibrate FRET, we compared the raft affinity of PFO to
that of two standardmarker proteins: LWpeptide, a TM-helix
peptide previously shown to have a high affinity for Ld
domains (32), and CT-B, a protein that binds to the raft-asso-
ciating lipid GM1 and has a very high affinity for Lo domains
(18,33). The expected FRET pattern was observed for LW
peptide andCT-B invesicles composed of 1:1DSPC/DMoPC
with 45 mol % cholesterol, 1:1 cholesterol/epicholesterol, or
1:1 coprostanol/epicholesterol. In all cases, CLoLd/CLd was
high for LW peptide and low for CT-B (Fig. 4).Biophysical Journal 105(12) 2733–2742
FIGURE 4 FRET-detected raft affinity of PFO in DSPC/DMoPC/sterol
vesicles forming coexisting Lo and Ld domains. Raft affinity of LW pep-
tide, CT-B, and PFO in MLVs (500 mM total lipid) composed of 1:1
DSPC/DMoPC with 45 mol % cholesterol (black bars), 45 mol % 1:1
cholesterol/epicholesterol (gray bars), or 45 mol % 1:1 coprostanol/epicho-
lesterol (striped bars) was measured in PBS pH 5.1. 2 mol % NBD-DPhPE
was used as the FRET acceptor. The CLoLd/CLd ratio represents the average
local acceptor concentration of acceptor around the donor (protein) in ves-
icles containing Lo and Ld domains (CLoLd) relative to that in a homoge-
nous bilayer (DMoPC with 45 mol % sterol) lacking domains (CLd).
CLoLd/CLd is high for a protein in Ld domains and low for a protein in
Lo domains. The actual FRET (F/Fo) data are shown in Fig. S3. For vesicles
containing a mixture of coprostanol and epicholesterol, in which PFO
binding is not complete, corrected CLoLd/CLd values are shown (see
Fig. S4 and Materials and Methods). Uncorrected F/Fo and CLoLd/CLd
data are shown in Fig. S5. Average (mean) values and SD values from
triplicates are shown.
2738 Lin and LondonNext, raft affinity was measured both for TM (WT) and
non-TM (prepore mutant) PFO using FRET. In vesicles
containing 1:1 DSPC/DMoPC with 45 mol % cholesterol,
the CLoLd/CLd ratio for both WT and prepore PFO was
between that of LWand CT-B but closer to CT-B, indicating
a considerable extent of association with (i.e., partition into)
DSPC- and cholesterol-rich Lo domains (Fig. 4). The
association of prepore PFO with Lo domains was slightly
stronger than that of WT PFO. This was also true in vesicles
containing 1:1 DSPC/DMoPC with 45 mol % 1:1 choles-
terol/epicholesterol.
In contrast, in vesicles containing 1:1 DSPC/DMoPC
with 45 mol % 1:1 coprostanol/epicholesterol (Fig. 4) or
with 45 mol % 1:2 coprostanol/epicholesterol (Fig. S6),
the CLoLd/CLd ratio for both WT and prepore PFO was
very high, in fact generally even higher than that of LW pep-
tide, indicating a very strong association with DMoPC- and
coprostanol-rich Ld domains. In this case WT PFO associ-
ated somewhat more with the ordered domains (likely to
be Lo domains) formed in this mixture than did the prepore
PFO. Because PFO does not bind epicholesterol, the sterol
that does bind to PFO, coprostanol, must largely determine
PFO location (see Discussion).Biophysical Journal 105(12) 2733–2742We previously showed that hydrophobic mismatch
between the TM segments of PFO and membrane domain
widths could influence the domains to which PFO binds
(19). Mismatch cannot explain the low raft affinity observed
with coprostanol-containing vesicles as the prepore protein,
which lacks TM domains and so cannot respond to hydro-
phobic mismatch, shows a raft affinity very close to that
of the WT protein.
Using this FRET assay a similar pattern of PFO domain
association with ordered and disordered domains was also
observed in the other lipid mixtures examined (Fig. 5), con-
firming that the localization of sterols to which PFO binds
determined the domain localization of PFO. It is noteworthy
that in cholesterol-containing vesicles, prepore PFO usually
had a slightly higher association with Lo domains than WT
PFO, but this pattern reversed in vesicles containing copro-
stanol and epicholesterol (see Discussion).DISCUSSION
Effect of lipid structure and sterol structure on
PFO localization
Rafts are well-established contributors to the action of many
bacterial toxins, such as PFO. Raft domains have been pro-
posed to promote toxin binding, oligomerization, and olig-
omer insertion into membranes to form pores (35,36).
However, in vitro studies using artificial lipid vesicles do
not provide evidence supporting the idea that rafts are
required for PFO assembly and action. In fact, at a fixed
cholesterol concentration PFO can more readily associate
and assemble in vesicles with a lipid composition forming
the loosely packed Ld state than one forming the Lo state
(15,16). This is not definitive, because in membranes with
coexisting ordered and disordered domains the cholesterol
concentration should be higher in the ordered domains
than in the disordered domains. Thus, the question of
whether and why PFO associates with ordered domains
must be studied in model membranes with coexisting
ordered and disordered domains.
To study this we prepared such model membrane vesicles
and then determined where PFO located. Our previous
studies showed that both sterol binding and hydrophobic
match between TM segment length and Lo domain bilayer
width can promote raft affinity (18,19). However, remaining
unanswered is the the question of whether PFO raft affinity
is directly related to the raft affinity of cholesterol. To
answer this question we examined the effect of sterol struc-
ture upon PFO raft interaction. Different sterols have
different tendencies to participate in ordered domains for-
mation (17,37,38). Coprostanol, which has a large bend
between the A and B rings (Fig. S7), interferes with tight
packing found in ordered domains and inhibits ordered
domain formation (17,38). This also implies that coprosta-
nol binds to Ld domains much better than to ordered
AB
C
FIGURE 5 FRET-detected raft affinity of PFO in vesicles containing
various lipid compositions forming coexisting Lo and Ld domains. (A)
Raft affinity of LW peptide, CT-B, and PFO in MLVs (500 mM total lipid)
composed of 1:1 SM/DMoPC with 45 mol % cholesterol (black bars) or
Protein-Raft Interaction 2739domains. Because coprostanol does not tend to form ordered
domains with saturated lipids, to study the effect of copro-
stanol on PFO raft affinity, we needed to use vesicles with
a mixture of coprostanol and epicholesterol. Epicholesterol,
which has a 3a-OH in place of the 3b-OH of cholesterol,
does not bind to PFO but does promote ordered domain for-
mation. Based on this, we reasoned, and experimentally
confirmed, that vesicles with a mixture of coprostanol and
epicholesterol would form coexisting ordered and disor-
dered domains. Using vesicles containing a mixture of cop-
rostanol and epicholesterol, FRET showed that, compared to
cholesterol-containing vesicles, PFO preferentially parti-
tioned into Ld domains. As only coprostanol could bind to
PFO in this sterol mixture, the localization of PFO must
have been mainly determined by the properties of PFO-
bound coprostanol. It should be noted that although direct
PFO-epicholesterol interactions would not form, the epicho-
lesterol could influence PFO association with rafts by
affecting the extent of exclusion of coprostanol from
ordered domains. PFO-bound coprostanol should be similar
to unbound coprostanol in tending to localize in Ld domains
because PFO only seems to bind to the -OH end of sterol
molecules. The membrane-exposed portion of PFO-bound
sterol should pack with membrane lipids similar to unbound
sterol (except in cases in which the exposure of the OH
group influences raft affinity, such as in ceramide-contain-
ing membranes, see below). Thus, we conclude that when
PFO is bound to a sterol that associates with rafts, its raft
association is promoted, and when PFO is bound to a sterol
that does not associate well with rafts, its association with
Ld domains is promoted.Relationship between sterol domain localization
and PFO domain localization
It is important to note that the localization of PFO in ordered
or disordered domains does not reflect the location of the45 mol % 1:1 coprostanol/epicholesterol (striped bars). (B) Raft affinity
of LW peptide, CT-B, and PFO in MLVs (500 mM total lipid) composed
of 1:1 DSPC/DPhPC with 40 mol % cholesterol (black bars) or
40 mol % 1:1 coprostanol/epicholesterol (striped bars). (C) Raft affinity
of LW peptide, CT-B, and PFO in MLVs (500 mM total lipid) composed
of 1:1 SM/DPhPC with 40 mol % cholesterol (black bars) or 40 mol %
1:1 coprostanol/epicholesterol (striped bars). Samples were prepared in
PBS pH 5.1. 2 mol % NBD-DPhPE was used as the FRET acceptor. The
CLoLd/CLd ratio represents the average local acceptor concentration of
acceptor around the donor (protein) in vesicles containing Lo and Ld
domains (CLoLd) relative to that in a homogenous bilayer (DMoPC with
40 mol % or 45 mol % sterol) lacking domains (CLd). (We could not use
DPhPC/sterol for the experiments in (B) and (C) because we could not
make MLVs of DPhPC with a high sterol concentration.) The actual
FRET (F/Fo) data are shown in Fig. S3. For vesicles containing a mixture
of coprostanol and epicholesterol, in which PFO binding is not complete,
corrected CLoLd/CLd values are shown (see Fig. S4 and Materials and
Methods). Uncorrected F/Fo and CLoLd/CLd data are shown in Fig. S5.
Average (mean) values and SD values from triplicates are shown.
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2740 Lin and LondonPFO-binding sterol before binding to PFO, but rather the
equilibrium location of PFO after it binds to membrane
and assembles into the TM oligomer (or prepore if that is
the final conformation). This is confirmed by the fact that
TM segment length affects domain location of PFO
(18,19). Because PFO initially binds to membranes in the
prepore form, PFO should initially bind to domains indepen-
dent of the TM segment length. Thus, if the initial domain
binding site determined final PFO domain localization,
PFO domain localization would not be affected by TM
segment length. This is contradicted by experimental obser-
vations using PFO with different TM segment lengths (19).
Another set of observations that shows final PFO location
is not the same as the location to which PFO binds come
from experiments using vesicle containing a mixture of
high-Tm lipid, low-Tm lipid, sterol and ceramide (18).
Ceramide displaces cholesterol from ordered domains, and
yet PFO in such membranes does locate in the ordered
domains (27). Presumably, the PFO first binds to the
cholesterol-containing Ld domains and then moves into
the ceramide-rich ordered domains, together with bound
sterol (18).
An interesting question is whether other proteins would
show behavior similar to that of PFO upon their binding
of a ligand/lipid that has a very strong or very weak affinity
for rafts. The effect of binding might be modest for a mono-
meric protein, and should be much stronger for an oligo-
meric one. This may be a very important factor in altering
raft affinity during clustering of membrane proteins into
complexes. In addition, even a modest change in raft affin-
ity, of a few-fold or less, might have important functional
consequences.
Another question is the extent to which the physical prop-
erties of ordered domains influence PFO localization. We
believe the exclusion of PFO from ordered domains in the
samples containing mixtures of coprostanol and epicholes-
terol cannot be explained by tight/highly ordered lipid
acyl chain packing excluding TM PFO segments. This is
because prepore PFO is a peripheral protein, lacking TM
segments, and it is also excluded from ordered domains in
membranes containing coprostanol. Instead, this is very
likely due to coprostanol being largely localized to disor-
dered domains. It is also possible that other structural
parameters that differ in epicholesterol-rich and choles-
terol-rich Lo domains have some influence on PFO localiza-
tion. Because the WT PFO associates with ordered domains
better than does the prepore PFO in coprostanol-containing
samples, its TM segments must promote association with
ordered domains in these samples. (It should be noted that
binding of various sterols by WT and prepore PFO is almost
identical, so that cannot explain the WT/prepore differences
(18).) How can this be if packing disfavors association of
TM segments with ordered domains? An explanation is
that, as we have previously shown, hydrophobic mismatch
is an important factor that controls PFO localization inBiophysical Journal 105(12) 2733–2742domains (19). Thus, in the samples containing epicholes-
terol and coprostanol, the mismatch between the length
spanned by the TM segments of PFO and Ld domain bilayer
width no doubt favors entry into the ordered domains, and
overcomes any effects due to poor packing between ordered
state lipids and amino acid side chains.Interpretation of FRET data
In interpreting FRET results, it is important to note that the
domains formed by coprostanol and epicholesterol were
different from those formed by cholesterol. First, relative
to cholesterol, stronger FRET between the donor (which
has some affinity for ordered domains) and the acceptor
(which partitions strongly into disordered domains) indi-
cated that lipids with a mixture of coprostanol and epicho-
lesterol formed a lesser amount of ordered domain
bilayers, and/or smaller ordered domains, and/or affected
the partitioning of the FRET probes in ordered and disor-
dered domains so as to decrease the segregation of donor
and acceptor (24). Second, as judged by FRET, ordered
domains formed by coprostanol and epicholesterol were
less thermally stable than that promoted by cholesterol.
The temperature dependence of domain melting indicated
that with the same phospholipid compositions, ~5C
decrease in the melting temperature Tm was observed for
vesicles containing 1:1 coprostanol/epicholesterol relative
to that for vesicles containing cholesterol and/or 1:1 choles-
terol/epicholesterol. This could either mean that the
domains disappear at a lower Tm value when coprostanol
is present, or that they fall below the size threshold for
detection by FRET at a lower temperature (24).
These issues make it important to calibrate the difference
in FRET response for PFO in membranes with different
sterols using proteins that act as Ld and Lo markers. Even
so, it should be noted that the partition of the marker pro-
teins could be affected to some degree by lipid composition,
and thus absolute values for raft affinity cannot be defined
from the FRET data. An alternative, which in favorable
cases can provide absolute values for PFO raft affinity, is
microscopy studies in giant vesicles (18,19). However, we
found large domains only formed at a concentration of sterol
too low to allow PFO binding to the vesicles (data not
shown). In any case, it is noteworthy that when FRET and
microscopy experiments can be carried out under similar
conditions, they have agreed as to PFO localization in
ordered and disordered domains (18,19).CONCLUSIONS
The affinity of PFO for ordered domains appears to be deter-
mined by a number of properties. One is binding to sterol.
The raft affinity of prepore PFO, which does not penetrate
bilayers, is totally dependent on the raft affinity of the sterol
to which it is bound. If the sterol packs well into ordered
Protein-Raft Interaction 2741domains, prepore PFO has a high affinity for ordered
domains, whereas if the sterol has a low affinity for
ordered domains, the prepore PFO has a low affinity for
them as well. The same properties must apply to WT PFO
in its transmembraneous pore-forming state. Whether the
protein-bound sterol is exposed to water is an additional fac-
tor that must be considered. Prior studies have shown that
free cholesterol has weak affinity for ceramide-rich domains
in vesicles that contain SM and low-Tm lipids because cer-
amide competes with cholesterol for interaction with SM
that minimizes the aqueous exposure of hydrophobic sites
on cholesterol or ceramide (27). This is not an issue for ste-
rol bound to PFO, because the PFO shields the sterol from
water. As a result, as prior studies have shown, PFO has a
strong affinity for ordered domains in ceramide-rich vesicles
(18). A third property that is important for PFO in a TM
state is hydrophobic mismatch between bilayer width and
TM segment length. Mismatch in which the width of a
domain is less than the length of PFO TM segments disfa-
vors association with that domain due to unfavorable expo-
sure of hydrophobic residues on PFO to water (19). This has
been shown to be true both when the mismatch involves Ld
domains and when it involves Lo domains. The effect of
mismatch should be greatest for oligomeric protein com-
plexes or oligomeric proteins such as PFO, because they
cannot tilt to lessen mismatch (19). It should be noted that
although these factors influencing Lo affinity would have
a cumulative effect, it would not necessarily involve them
being strictly additive. It should also be noted that these
principles should apply to a-helical proteins as well as to
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